Advertisement

Topics

ERYTECH Provides Business Update and Reports Financial Results for Full Year 2016

12:37 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Conference call and webcast on Friday, March 3rd at 15:00 pm CET/09:00 am EST Activities for resubmission of European Marketing Authorization Application (MAA) for eryaspase (GRASPA) in relapsed and refractor...

Other Sources for this Article

ERYTECH
Gil Beyen
Chairman and CEO
or
Eric Soyer
CFO and COO
+33 4 78 74 44 38
investors@erytech.com
or
The Ruth Group
Investor relations
Lee Roth, +1 646 536 7012
lroth@theruthgroup.com
or
Media relations
Kirsten Thomas, +1 508 280 6592
kthomas@theruthgroup.com
or
NewCap
Julien Perez
Investor relations
or
Nicolas Merigeau
Media relations
+33 1 44 71 98 52
erytech@newcap.eu

NEXT ARTICLE

More From BioPortfolio on "ERYTECH Provides Business Update and Reports Financial Results for Full Year 2016"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...